PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HOLX vs. BRK-B
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HOLX and BRK-B is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

HOLX vs. BRK-B - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hologic, Inc. (HOLX) and Berkshire Hathaway Inc. (BRK-B). The values are adjusted to include any dividend payments, if applicable.

600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%1,800.00%2,000.00%AugustSeptemberOctoberNovemberDecember2025
659.74%
1,808.02%
HOLX
BRK-B

Key characteristics

Sharpe Ratio

HOLX:

-0.03

BRK-B:

1.42

Sortino Ratio

HOLX:

0.07

BRK-B:

2.04

Omega Ratio

HOLX:

1.01

BRK-B:

1.26

Calmar Ratio

HOLX:

-0.03

BRK-B:

2.47

Martin Ratio

HOLX:

-0.11

BRK-B:

6.10

Ulcer Index

HOLX:

5.33%

BRK-B:

3.38%

Daily Std Dev

HOLX:

17.38%

BRK-B:

14.60%

Max Drawdown

HOLX:

-93.75%

BRK-B:

-53.86%

Current Drawdown

HOLX:

-18.22%

BRK-B:

-8.37%

Fundamentals

Market Cap

HOLX:

$16.51B

BRK-B:

$974.44B

EPS

HOLX:

$3.32

BRK-B:

$49.48

PE Ratio

HOLX:

21.91

BRK-B:

9.13

PEG Ratio

HOLX:

0.90

BRK-B:

10.06

Total Revenue (TTM)

HOLX:

$3.02B

BRK-B:

$276.52B

Gross Profit (TTM)

HOLX:

$1.69B

BRK-B:

$48.42B

EBITDA (TTM)

HOLX:

$990.50M

BRK-B:

$98.94B

Returns By Period

In the year-to-date period, HOLX achieves a -0.54% return, which is significantly higher than BRK-B's -2.34% return. Over the past 10 years, HOLX has underperformed BRK-B with an annualized return of 9.51%, while BRK-B has yielded a comparatively higher 11.63% annualized return.


HOLX

YTD

-0.54%

1M

-4.51%

6M

-7.71%

1Y

-1.44%

5Y*

6.29%

10Y*

9.51%

BRK-B

YTD

-2.34%

1M

-3.48%

6M

4.29%

1Y

21.74%

5Y*

14.19%

10Y*

11.63%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HOLX vs. BRK-B — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HOLX
The Risk-Adjusted Performance Rank of HOLX is 4343
Overall Rank
The Sharpe Ratio Rank of HOLX is 4747
Sharpe Ratio Rank
The Sortino Ratio Rank of HOLX is 3737
Sortino Ratio Rank
The Omega Ratio Rank of HOLX is 3737
Omega Ratio Rank
The Calmar Ratio Rank of HOLX is 4747
Calmar Ratio Rank
The Martin Ratio Rank of HOLX is 4747
Martin Ratio Rank

BRK-B
The Risk-Adjusted Performance Rank of BRK-B is 8686
Overall Rank
The Sharpe Ratio Rank of BRK-B is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of BRK-B is 8383
Sortino Ratio Rank
The Omega Ratio Rank of BRK-B is 8181
Omega Ratio Rank
The Calmar Ratio Rank of BRK-B is 9393
Calmar Ratio Rank
The Martin Ratio Rank of BRK-B is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HOLX vs. BRK-B - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Hologic, Inc. (HOLX) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HOLX, currently valued at -0.03, compared to the broader market-4.00-2.000.002.00-0.031.42
The chart of Sortino ratio for HOLX, currently valued at 0.07, compared to the broader market-4.00-2.000.002.004.000.072.04
The chart of Omega ratio for HOLX, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.26
The chart of Calmar ratio for HOLX, currently valued at -0.03, compared to the broader market0.002.004.006.00-0.032.47
The chart of Martin ratio for HOLX, currently valued at -0.11, compared to the broader market0.0010.0020.00-0.116.10
HOLX
BRK-B

The current HOLX Sharpe Ratio is -0.03, which is lower than the BRK-B Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of HOLX and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
-0.03
1.42
HOLX
BRK-B

Dividends

HOLX vs. BRK-B - Dividend Comparison

Neither HOLX nor BRK-B has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HOLX vs. BRK-B - Drawdown Comparison

The maximum HOLX drawdown since its inception was -93.75%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for HOLX and BRK-B. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-18.22%
-8.37%
HOLX
BRK-B

Volatility

HOLX vs. BRK-B - Volatility Comparison

Hologic, Inc. (HOLX) has a higher volatility of 5.11% compared to Berkshire Hathaway Inc. (BRK-B) at 3.61%. This indicates that HOLX's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%AugustSeptemberOctoberNovemberDecember2025
5.11%
3.61%
HOLX
BRK-B

Financials

HOLX vs. BRK-B - Financials Comparison

This section allows you to compare key financial metrics between Hologic, Inc. and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab